Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors
Ashlyn Parkhurst(Johns Hopkins University), Jeffrey Rubens(Johns Hopkins University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Cody J. Peer(National Institutes of Health), Barbara S. Slusher(Johns Hopkins University), Sabrina Wang(Johns Hopkins Medicine), Eric H. Raabe(Johns Hopkins University), Kristen Malebranche(Johns Hopkins University), Jesse Alt(Johns Hopkins University), Arman Odabas(National Institutes of Health), Harpreet Kaur(Johns Hopkins University), William D. Figg(National Institutes of Health), Micah J. Maxwell(Johns Hopkins University), Tyler Findlay(Johns Hopkins University), Katherine E. Warren(Brigham and Women's Hospital)
Cited by 8
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711